IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2 biotech developing therapies for diabetes and obesity.
Industry: Health Care
Latest Trade: ()
First Day Return:
Return from IPO:
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 11/17/2023 |
Offer Price | |
Price Range n/a | |
Offer Shares (mm) | n/a |
Deal Size ($mm) | $100 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | |
Offer Price | |
Price Range n/a | |
Offer Shares (mm) | n/a |
Deal Size ($mm) | $100 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
J.P. Morgan |
BofA Securities |
more |
Company Data | |
---|---|
Headquarters | Berkeley, CA, United States |
Founded | 2008 |
Employees | 59 |
Website carmot.us |